FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3053087 · Received April 11, 2013

Report

Report Number
2124215-2013-04540
Event Type
Injury
Date Received
April 11, 2013
Date of Event
February 11, 2013
Report Date
March 11, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS LEAD WAS SURGICALLY ABANDONED AND WILL NOT BE RETURNED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A NORMAL DEVICE CHANGE OUT, DEFIBRILLATION THRESHOLD (DFT) TEST WAS PERFORMED AT WHICH TIME A FAULT CODE WAS OBSERVED. TWO SEPARATE DEVICES WERE ATTEMPTED. IT WAS DETERMINED THAT THE RIGHT VENTRICULAR (RV) LEAD WAS FAULTY. FLUORO WAS PERFORMED AND CONFIRMED A FRACTURE FOUND ON THE RIGHT VENTRICULAR (RV) LEAD. THE LEAD WAS CAPPED AND A NEW DF-4 LEAD WAS IMPLANTED ALONG WITH A NEW DF-4 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD). THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156892 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 82 YR Life Threatening| R 0292| N161| 4087| 4555| N160| H217| 1298| 4088| 0185| N119